Bazedoxifene helps reduce vertebral fracture risk after menopause.(Endocrinology) From: Internal Medicine News | Date: December 1, 2007| Author: Muirhead, Greg | COPYRIGHT 2007 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

HONOLULU -- Bazedoxifene is safe and effective in reducing the risk of new vertebral fractures in postmenopausal women with osteoporosis, according to the results of a 3-year, phase III, placebo-controlled trial presented at the annual meeting of the American Society for Bone and Mineral Research.

"In postmenopausal women with osteoporosis, bazedoxifene reduced the incidence of new vertebral fractures up to 42%," said Dr. Stuart L. Silverman, medical director of the Oste...